Drugs company questions patent pool concept

Emma Barraclough, Brussels


A lawyer for one of the world’s biggest pharmaceutical companies has said that pooling patents over drugs will not solve the major problems of access to medicines

Speaking at the Competition 2009 conference in Brussels on Friday, Stéphane Drouin, head of European patents at Pfizer, said that IP is not a major issue when it comes to accessing drugs in least developed countries.


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

Related Articles

Most read articles

Latest Country Updates

Supplements